Buprenorphine/Naloxone
Buprenorphine/naloxone and methadone opioid replacement therapy : a 2 year follow up study and health economic analysis
... and buprenorphine-based drugs are licensed for this purpose in the UK with over 25,000 peo- ple prescribed in Scotland, mostly receiving ...or buprenorphine/naloxone ORT, comparing 2-year retention ...
9
Patients that benefit from buprenorphine naloxone on medically assisted treatment for opioid dependence in Malaysia
... on buprenorphine-naloxone combination therapy at 2 mg daily and diazepam equivalent of zolpidem dose (25 mg a ...her buprenorphine-naloxone therapy at 2 mg daily and is now ...of ...
5
Neuropsychological function is improved among opioid dependent adults who adhere to opiate agonist treatment with buprenorphine-naloxone: a preliminary study
... a limitation, as it is unknown whether our findings are generalizable to a predominantly non-Hispanic white sample. While this study provided a comprehensive over- view of participants ’ current substance use, an ...
7
Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX)
... daily buprenorphine dose (16 mg/buprenor- phine is the standard target dose in ART) tapered for a standard 2 mg/day, while a lower dose (2–4 mg bupre- norphine/day) is typically administered to illicit heroin ...
10
A case report on the treatment of complex chronic pain and opioid dependence by a multidisciplinary transitional pain service using the ACT Matrix and buprenorphine/naloxone
... a buprenorphine/naloxone combination can be a helpful medi- cation for appropriate candidates in a chronic pain program, where proper screening, diagnosis, and open discussions with patient and family are ...
9
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
... of buprenorphine for treating heroin addiction [8,14-16]. A buprenorphine/ naloxone (B/N) combination (Suboxone ® , Reckitt Beckin- ser Pharmaceuticals Limited) was approved by the Eur- opean ...
9
Observational study of the safety of buprenorphine+naloxone in pregnancy in a rural and remote population
... to buprenorphine +naloxone is small and therefore may give a biased esti- mation of this ...to buprenorphine+nalox- one also had no observable impact on Apgar scores or treatment for ...
7
<p>Perioperative Pain Management for Median Sternotomy in a Patient on Chronic Buprenorphine/Naloxone Maintenance Therapy: Avoiding Opioids in Patients at Risk for Relapse</p>
... current buprenorphine-naloxone and alprazolam dosing in addition to acetaminophen 1000 mg IV every 6 hrs, ketorolac 30 mg IV every 6 hrs and gabapentin 300 mg ...
5
Apelt, Sabine M. (2019): Safety and effectiveness of Buprenorphine-Naloxone sublingual tablet in the treatment of opioid use disorder. Dissertation, LMU München: Medizinische Fakultät
... of buprenorphine- ...of buprenorphine- naloxone between 16–24 mg/day [ 33 ] , patients observed in this non-interventional study received lower doses of 10 mg/day on average, which decreased to an ...
80
Unit-Dose Packaging and Unintentional Buprenorphine-Naloxone Exposures
... SUBJECT: Buprenorphine accounts for the most opioid-related hospital admissions and is the third highest in serious medical outcomes among children when compared with other ...of buprenorphine- ...
10
Problems in Inducing Interferon Therapy of Opiate Addicts with Chronic Hepatitis C Who Are In Substitution Maintenance Therapy with Buprenorphine/Naloxone (Suboxone®)
... with buprenorphine / naloxone (Suboxone®) at the Department of psychiatric in Tuzla, any sign that a patient positive for chronic HCV was admitted to the treatment has caused unease among psychiatrists and ...
5
Buprenorphine-naloxone use in pregnancy for treatment of opioid dependence
... NAS, buprenorphine-naloxone can be safely used in ...to buprenorphine-naloxone had significantly larger (normal) birth weights than pregnancies exposed to other narcotics did (P = ...taking ...
7
Outcomes among buprenorphine-naloxone primary care patients after Hurricane Sandy
... daily buprenorphine doses and obtaining additional supplies from friends or family was common following ...of buprenorphine from friends or family also receiving buprenorphine ...of ...
7
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
... ferent buprenorphine formulations under chronic dosing conditions has also been studied, and it is possible that the buprenorphine in Suboxone has a slightly higher sub- lingual bioavailability than the ...
6
Evaluation of 6 remote First Nations community-based buprenorphine programs in northwestern Ontario
... added buprenorphine-naloxone to its formulary, and the Non- Insured Health Benefits program (which provides drug coverage for First Nations communities) followed ...prescribe buprenorphine- ...
9
Primary care management of opioid use disorders
... allowed buprenorphine as a general benefit on the public drug formulary (British Columbia, Alberta, Ontario, and Newfoundland and Labrador, as well as Non-Insured Health Benefits and Correctional Services) but ...
6
Low-dose naloxone provides an abuse-deterrent effect to buprenorphine
... plasma buprenorphine concentrations comparable to a 2 mg buprenorphine–naloxone (BN) sublingual tablet have been achieved with a ...a naloxone challenge ...(IV) naloxone doses of ...of ...
8
Opioid use disorder and type 2 diabetes mellitus
... had buprenorphine- naloxone substitution programs ranging in size from 33 to 160 ...receiving buprenorphine-naloxone and 573 patients with diabe- ...
5
Non-prescribed use of methadone and buprenorphine prior to opioid substitution treatment: lifetime prevalence, motives, and drug sources among people with opioid dependence in five Swedish cities
... Regarding the treatment variables, a greater share of patients had used those substances that they were later prescribed in OST. This is especially clear in the use of buprenorphine/naloxone. The ...
15
New developments in the management of opioid dependence: focus on sublingual buprenorphine–naloxone
... dependence. Buprenorphine, a partial opioid agonist, has been found by numerous stud- ies to be an effective and safe medication in the treatment of opioid ...present, buprenorphine is available as a ...
14